The Faces Symbol Test,a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study
Restricted accessOtherFirst published online April, 2007
The Faces Symbol Test,a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study
Reliable, language-independent, short screening instruments to test for cognitive function in patients with multiple sclerosis (MS) remain rare, despite the high number of patients affected by cognitive decline. We developed a new, short screening instrument, the Faces Symbol Test (FST), and compared its diagnostic test characteristics with a composite of the Digit Symbol Substitution Test (DSST) and the Paced Auditory Serial Addition Test (PASAT), in 108 MS patients and 33 healthy controls. An Informant-Report Questionnaire, a Self-Report Questionnaire, and a neurologist's estimation of the Every Day Life Cognitive Status were also applied to the MS patients. The statistical analyses comprised of a receiver operating characteristic analysis for test accuracy and for confounding variables. The PASAT and DSST composite score estimated that 36.5% of the MS patients had cognitive impairment. The FST estimated that 40.7% of the MS patients were cognitively impaired (sensitivity 84%; specificity 85%). The FST, DSST and PASAT results were significantly correlated with the patients' physical impairment, as measured by the Expanded Disability Status Scale (EDSS). The results suggest that the FST might be a culture-free, sensitive, and practical short screening instrument for the detection of cognitive decline in patients with MS, including those in the early stages. Multiple Sclerosis 2007; 13: 402-411. http://msj.sagepub.com
Rao SM , Leo GJ , Bernardin L. , Unverzagt F.Cognitive dysflunction in multiple sclerosis: I. Frequency, patterns, and prediction . Neurology1991; 41: 685-91 .
2.
Achiron A. , Barak Y.Cognitive impairment in probable multiple sclerosis . J Neurol Neurosurg Psychiatry2003; 74: 443-46 .
3.
Amato MP , Ponziani G. , Siracusa G. , Sorbi S.Cognitive dysflunction in early-onset multiple sclerosis . A reappraisal aflter 10 years. Arch Neurol2001; 58: 1602-606 .
4.
Rao SM , Leo GJ , Ellington L. , Nauertz T. , Bernardin L. , Unverzagt F.Cognitive dysflunction in multiple sclerosis: II. Impact on employment and social flunctioning . Neurology1991; 41: 692-96 .
5.
Benedict Rhb , Wahlig E. , Bakshi R. , Fishman I. , Munschauer F. , Zivadinov R. et al. Predicting quality ofl lifle in multiple sclerosis: accounting flor physical disability, flatigue, cognition, mood disorder, personality, and behaviour change . J Neurol Sci2005; 231: 29-34 .
6.
Benedict Rhb , Munschauer F. , Linn R. , Miller C. , Murphy E. , Foley F. et al. Screening flor multiple sclerosis cognitive impairment using a selfl-administered 15-item questionnaire . Mult Scler2003; 9: 95-101 .
7.
Beatty WW , Goodkin DEScreening flor cognitive impairment in multiple sclerosis. An evaluation ofl the Mini-Mental State Examination . Arch Neurol1990; 47: 297-301 .
8.
Swirsky-Sacchetti T. , Field HL , Mitchell DR , Seward J. , Lublin FD , Knobler RL et al. The sensitivity ofl the Mini-Mental State Exam in the white matter dementia ofl multiple sclerosis . J Clin Psychol1992; 48: 779-86 .
9.
Beatty WW , Paul RH , Wilbanks SL , Hames KA , Blanco CR , Goodkin DEIdentiflying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination flor Cognitive Impairment (SEFCI) . Neurology1995; 45: 718-23 .
10.
Basso MR , Beason-Hazen S. , Lynn J. , Rammohan K. , Bornstein RAScreening flor cognitive dysflunction in multiple sclerosis . Arch Neurol1996; 53: 980-84 .
11.
Rao SM and the Cognitive Function Study Group of the National Multiple Sclerosis Society.A manual for the Brief Repeatable Battery of Neuropsychological Tests in multiple sclerosis. Medical College ofl Wisconsin , 1990.
12.
Bever CT Jr, Grattan L. , Panitch HS , Johnson KPThe Briefl Repeatable Battery ofl Neuropsychological Tests flor multiple sclerosis: a preliminary serial study . Mult Scler1995 ; 1: 165-69 .
13.
Boringa JB , Lazeron Rhc , Reuling Iew , Ader HJ , Pfennings L. , Lindeboom J. et al. TheBriefl Repeatable Battery ofl Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice . Mult Scler2001; 7: 263-67 .
14.
Scherer P. , Baum K. , Bauer H. , Göhler H. , Miltenburger C.Normierung der Briefl Repeatable Battery ofl Neuropsychological Tests (BRB-N) flür den deutschsprachigen Raum und Anwendung bei schubflörmig remittierenden und sekundär progredienten Multiple-Sklerose-Patienten . Nervenarzt2004; 75: 984-90 .
15.
Gronwall D.Paced Auditory Serial Addition Task: a measure ofl recovery flrom concussion . Percept Mot Skills1977; 44: 367-73 .
16.
Smith A.Symbol Digit Modalities Test. Western Psychological Services , 1991.
17.
Fischer JS , Rudick RA , Cutter GR , Reingold SCThe Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment . National MS Society Clinical Outcomes Assessment Task Force. Mult Scler1999; 5: 244-50 .
18.
Benedict Rhb , Cox D. , Thompson LL , Foley F. , Weinstock-Guttman B. , Munschauer F.Reliable screening flor neuropsychological impairment in multiple sclerosis . Mult Scler2004; 10: 675-78 .
19.
Franklin GM , Heaton RK , Nelson LM , Filley CM , Seibert C.Correlation ofl neuropsychological and MRI findings in chronic/progressive multiple sclerosis . Neurology1988; 38: 1826-29 .
20.
Smith A. , Pondsford J. , Kinsella G.Attentional deficits flollowing closed head injury . J Clin Exp Neuropsychol1992; 14: 822-38 .
Lezak MDNeuropsychological assessment, third edition. Oxflord University Press , 1995: 379-80.
23.
Scherer P. , Rohr A. , Wilke-Burger H. , Burger-Deinerth E. , Boldt H. , Anvari K. et al. TheFaces Symbol Test: a newly developed sensitive neuropsychological screening instrument flor cognitive decline related to multiple sclerosis - first results ofl the Berlin Multi-Centre FST validation study . Mult Scler2003; 9: S24 .
24.
Scherer P. , Zahrnt S. , Ringel I.Der Faces-Symbol-Test (FST) als Screeninginstrument zur Erflassung kognitiver Störungen bei Multipler Sklerose (MS) . Aktuelle Neurol2003; 30: S116 .
25.
Breitkopf S. , Scherer P. , Kaskel P. , Schilli MBThe Faces Symbol Test allows a reliable cognitive screening in multiple sclerosis . Mult Scler2005; 11: S71 .
26.
McDonald WI , Compston A. , Edan G. , Goodkin D. , Hartung HP , Lublin FD et al. Recommended diagnostic criteria flor multiple sclerosis: guidelines flrom the International Panel on the diagnosis ofl multiple sclerosis . Ann Neurol2001; 50: 121-27 .
27.
Lublin FD , Reingold SCDefining the clinical course ofl multiple sclerosis: results ofl an international survey . Neurology1996; 46: 907-11 .
28.
Fischer JS , Jak AJ , Kniker JE , Rudick RA , Cutter G.Administration and scoring manual for the Multiple Sclerosis Functional Composite measure (MSFC). National Multiple Sclerosis Society , 2001.
29.
Kurtzke JFRating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS) . Neurology1983; 33: 1444-52 .
30.
Montgomery SA , Asberg M.A new depression scale designed to be sensitive to change . Br J Psychiatry1979; 134: 382-89 .
31.
Krupp LB , LaRocca NG , Muir-Nash J, Steinberg AD. The flatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus . Arch Neurol1989; 46: 1121-23 .
32.
Krupp LB , Coyle PK , Doscher C. , Miller A. , Cross AH , Jandorf L.et al.Fatigue therapy in multiple sclerosis: results ofl a double-blind, randomized, parallel trial ofl amantadine, pemoline, and placebo . Neurology1995; 45: 1956-61 .
33.
Scherer P. , Pohle S. , Polzer U. , Ringel I.Kognitive Störungen, Depression und Fatigue bei MS . Aktuelle Neurologie2002; 2: S158 .
34.
Wechsler D.Handanweisung zum Hamburg-WechslerIntelligenztest für Erwachsene (HAWIE). Huber , 1982.
35.
DeLong ER , DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach . Biometrics1988; 44: 837- 45 .
36.
Hanley JA , McNeil BJThe meaning and use ofl the area under a receiver operating characteristic (ROC) curve . Radiology1982; 143: 29-36 .
37.
Hanley JA , McNeil BJ. A method ofl comparing the areas under receiver operating characteristic curves derived flrom the same cases . Radiology1983; 148: 83943 .
38.
Centor RMThe use ofl ROC curves and their analyses . Med Dec Making1991; 11: 102-43 .
39.
Kaskel P. , Berking C. , Sander S. , Volkenandt M. , Peter RU , Krähn G.S-100 protein in peripheral blood: a marker flor melanoma metastases . J Am Acad Dermatol1999; 41: 962-69 .
Aupperle RL , Beatty WW , Shelton FdeN, Goutkowsky ST. Three screening batteries to detect cognitive impairment in multiple sclerosis . Mult Scler2002; 8: 382-89 .
44.
Fisk JD , Archibald CJLimitations ofl the Paced Auditory Serial Addition Test as a measure ofl working memory in patients with multiple sclerosis . J Int Neuropsychol Soc2001; 7: 363-72 .
45.
Lezak MDNeuropsychological assessment, third edition. Oxflord University Press , 1995: 372-78.
46.
Fischer JS , Priore RL , Jacobs LD , Cookfair DL , Rudick RA , Herndon RM et al. Neuropsychological eflflects ofl interfleron ß-1a in relapsing multiple sclerosis . Ann Neurol2000; 48: 885- 92 .
47.
Marrie RA , Miller DM , Chelune GJ , Cohen JAValidity and reliability ofl the MSQLI in cognitively impaired patients with multiple sclerosis . Mult Scler2003; 9: 621-26 .
48.
Scherer P. , Rohr A.Corticoid eflflects on working memory in multiple sclerosis patients with acute relapses . Mult Scler2004; 10: S122-23 .
